Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

Oncological transformation in vitro of hepatic progenitor cell lines isolated from adult mice

dc.contributor.authorOlivera-Salazar, Rocío
dc.contributor.authorGarcía-Arranz, Mariano
dc.contributor.authorSánchez Muñoz, Aranzazu
dc.contributor.authorOlmedillas-López, Susana
dc.contributor.authorVega-Clemente, Luz
dc.contributor.authorSerrano, Luis Javier
dc.contributor.authorHerrera González, Blanca María
dc.contributor.authorGarcía-Olmo, Damián
dc.date.accessioned2024-07-24T11:48:29Z
dc.date.available2024-07-24T11:48:29Z
dc.date.issued2022-02-24
dc.description.abstractColorectal cancer cells can transfer the oncogene KRAS to distant cells, predisposing them to malignant transformation (Genometastasis Theory). This process could contribute to liver metastasis;besides, hepatic progenitor cells (HPCs) have been found to be involved in liver malignant neoplasms. The objective of this study is to determine if mouse HPCs—Oval cells (OCs)—are susceptible to incorporate Kras GAT (G12D) mutation from mouse colorectal cancer cell line CT26.WT and if OCs with the incorporated mutation behave like malignant cells. To achieve this, three lines of OCs in diferent conditions were exposed to CT26.WT cells through transwell co-culture for a week. The presence of KrasG12D and capacity to form tumors were analyzed in treated samples by droplet digital PCR and colony-forming assays, respectively. The results showed that the KrasG12D mutation was detected in hepatic culture conditions of undiferentiated OCs and these cells were capable of forming tumors in vitro. Therefore, OCs are susceptible to malignant transformation by horizontal transfer of DNA with KrasG12D mutation in an undiferentiated condition associated with the liver microenvironment. This study contributes to a new step in the understanding of the colorectal metastatic process.
dc.description.departmentDepto. de Bioquímica y Biología Molecular
dc.description.facultyFac. de Farmacia
dc.description.refereedTRUE
dc.description.sponsorshipInstituto de Salud Carlos III (ISCIII)
dc.description.sponsorshipFundación Conchita Rábago
dc.description.statuspub
dc.identifier.doi10.1038/s41598-022-06427-w
dc.identifier.issn2045-2322
dc.identifier.officialurlhttps://doi.org/10.1038/s41598-022-06427-w
dc.identifier.urihttps://hdl.handle.net/20.500.14352/107121
dc.journal.titleScientific Reports
dc.language.isoeng
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//RD16%2F0011%2F0013/ES/Red de Terapia Celular (TerCel)/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F01052/ES/VALOR DEL ESTUDIO DE LA PRESENCIA DIFERENCIAL DE EXONES EN LA BIOPSIA LIQUIDA DE PACIENTES CON CANCER DE RECTO QUE SIGUEN LA ESTRATEGIA “WATCH AND WAIT”/
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.cdu577.1
dc.subject.cdu577.2
dc.subject.ucmBiología molecular (Farmacia)
dc.subject.ucmBioquímica (Farmacia)
dc.subject.unesco32 Ciencias Médicas
dc.titleOncological transformation in vitro of hepatic progenitor cell lines isolated from adult mice
dc.typejournal article
dc.type.hasVersionAM
dspace.entity.typePublication
relation.isAuthorOfPublication5ad3e4ea-8ef8-42a2-8f7b-ff372dc8d837
relation.isAuthorOfPublication5827f207-2122-4faf-b1f3-7576ac372d56
relation.isAuthorOfPublication.latestForDiscovery5ad3e4ea-8ef8-42a2-8f7b-ff372dc8d837

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Olivera-Salazar Scientific Reports 2022.pdf
Size:
3.17 MB
Format:
Adobe Portable Document Format

Collections